| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e4c78d5eeb74d2b841bdaecbe5beaea7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fabf28acc58617048156c31f2bf5d1c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_36a9839a140a17572636ed7d9f34476b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-1821
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4702 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-18 |
| filingDate |
2018-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4f7156026f6457ab918df9ae7df5eaa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f559e76e86fd7e96464f22a2d2cfd68f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15f016d823435ad8fef1af5923639c0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8885b0592654ffdf815c5ac2943bd77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dacc4ab61c64aba8a80d334a11f33b9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50c1d5933a4f07da7e5a671247e4db56 |
| publicationDate |
2019-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019012157-A9 |
| titleOfInvention |
THERAPEUTIC NANOCONJUGATES AND USES THEREOF |
| abstract |
The present invention relates to nanostructured conjugates, more specifically nanostructured fusion proteins, suitable for the selective delivery of their therapeutic agents conjugated to specific cell and tissue types. The invention also relates to nanoparticles comprising such nanostructured proteins and their therapeutic uses. |
| priorityDate |
2017-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |